-
-
-
-
-
-
-
Summit Therapeutics publishes HARMONi Phase III lung cancer trial data
-
-
-
-
-
-
-
Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter and Six Months Ended June 30, 2026
-
-
-
-
-
-
-
Encouraging Global Phase II Ivonescimab Data in First-Line Metastatic Colorectal Cancer Presented at ASCO 2026
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Summit Therapeutics plc (SMMT)
-
-
-
15,818 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

